On December 8, 2025 Biosenta has entered into a Field Test and Research Agreement with Livespace Homes to evaluate the ...

Scientists working to enhance brain-computer interface (BCI) technology—which allows people to control devices with their ...

Using proteins from a common tobacco plant virus, McGill chemistry researchers have developed a simple, eco-friendly way to ...

Israeli start-up New Phase is testing nanoparticle technology to target metastatic cancer, aiming to destroy tumors while ...

Subsense announced that it added $10 million in new capital to support its nanoparticle-based brain-computer interface (BCI) ...

Scientists working to enhance brain-computer interface (BCI) technology—which allows people to control devices with their thoughts—have found they can improve the performance of electrodes implanted ...

Subsense emerged from stealth in February 2025 and is developing a nanoparticle-based brain-computer interface (BCI).

The latest update is out from Biosenta Inc ( (TSE:ZRO) ).

Clinical trials are currently underway at Rabin Medical Center, Beilinson Hospital, where 27 patients are participating ...

To our immune system, a potentially lifesaving gene therapy can look a lot like a dangerous infection. That's because most ...